Effect of Virtual Reality on Depression in Adolescent Females
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Virtual reality headset, Selective serotonin reuptake inhibitors(SSRIs).
- Who it may be relevant to
- Registry conditions: Depression. Basic parameters: 13 years — 18 years · Female.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
The purpose of this study is to investigate the effect of virtual reality on depression in adolescent females.
Detailed description
Depression is most commonly found in adolescents and large percentage of them don't receive management.
People with depression usually experience at least five of the following 9 characteristics: (1) people feel sad and unhappy; (2) have less interest in doing things; (3) individuals do not follow a diet, but their weight losses are obvious; (4) their appetites change and their weight may increase; (5) they suffer insomnia or drowsiness; (6) some people have mental agitation; (7) they feel that life is meaningless, or they feel guilty; (8) they have difficulty concentrating; or (9) they have suicidal thoughts . Individuals who develop depression may have experienced an anxiety disorder earlier in life.
Depression is most commonly found in adolescents and large percentage of them don't receive management The application of emerging technology in health promotion has generated substantial public interest. Among the emerging technologies that may potentially aid in the treatment of depression, virtual reality (VR) is the most exciting and technologically-advanced.
A virtual environment provides a greater degree of control for the therapists to customize, reproduce, and tweak several treatment parameters according to the patient's needs.
Interventions
- Device Virtual reality headset
Participants will use virtual reality glasses during treatment sessions for approximately 30 minutes per session, once per week for 8 weeks . - Drug Selective serotonin reuptake inhibitors(SSRIs)
All adolescent females in the control group will receive antidepressant drugs Selective serotonin reuptake inhibitors(SSRIs) for 8 weeks as described by the psychiatrist
Primary outcome measures
- 1-Calculation the score of Beck Depression Inventory [BDI] to assess the severity of depression. [Time frame: 8 weeks]
- 2-Calculation the score of KIDSCREEN-52 questionnaire to assess the quality of life [Time frame: 8 weeks]
Eligibility criteria
Inclusion criteria
- Adolescent females suffer from depression who are diagnosed and referred by the psychiatrist.
- Their ages will range from 13-18 years old
- Their BMI will range from 15.5 -24.9 kg/m2
- They are interested in their mental state or with depressive disorders and their score on Beck depression inventory (BDI) between 11-30 (mild to moderate depression)
- They are interested in using VR technology to improve mental health problems.
Exclusion criteria
- Patients who suffer from major diseases other than depression.
- Adolescents who are not interested in VR.
- Patients with severe mental illness or repetitive suicidal trials .
- Patients who receive any other psychotherapy.
- Obese patients with BMI more than 26.2 -29.5kg/m2
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07452341 · 012/006001